{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:55:32Z","timestamp":1769216132237,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.clcc.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T02:00:29Z","timestamp":1587002429000},"page":"e164-e180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response"],"prefix":"10.1016","volume":"19","author":[{"given":"Chien-Chih","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-4442","authenticated-orcid":false,"given":"Yih-Lin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2020.04.002_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2020.04.002_bib2","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib3","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation vs. 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study","volume":"30","author":"Cise\u0142","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib4","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1200\/JCO.2013.53.7753","article-title":"Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04","volume":"32","author":"O\u2019Connell","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectablerectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2020.04.002_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/0284186X.2019.1629009","article-title":"Emerging trends in the treatment of rectal cancer","volume":"58","author":"Minsky","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/0284186X.2019.1594363","article-title":"Patient explicit consideration of tradeoffs in decision making about rectal cancer treatment: benefits for decision process and quality of life","volume":"58","author":"Pieterse","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0284186X.2018.1551622","article-title":"Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort study","volume":"58","author":"Couwenberg","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib11","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.clcc.2020.04.002_bib12","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2020.04.002_bib13","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-13-2830","article-title":"Prognostic and predictive values of the immunoscore in patients with rectal cancer","volume":"20","author":"Anitei","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2020.04.002_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/DCR.0000000000001332","article-title":"Prognostic impact of tumor-infiltrating lymphocytes in primary and metastatic colorectal cancer: a systematic review and meta-analysis","volume":"62","author":"Kong","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2020.04.002_bib15","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jamaoncol.2019.2311","article-title":"Multiomics prediction of response rates to therapies to inhibit programmed cell death 1 and programmed cell death 1 ligand 1","volume":"5","author":"Lee","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061324","article-title":"Immune checkpoints as a target for colorectal cancer treatment","volume":"18","author":"Passardi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clcc.2020.04.002_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00262-019-02458-x","article-title":"Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer","volume":"69","author":"Bains","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clcc.2020.04.002_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clcc.2020.04.002_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cmpb.2019.06.022","article-title":"Prediction of early colorectal cancer metastasis by machine learning using digital slide images","volume":"178","author":"Takamatsu","year":"2019","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.clcc.2020.04.002_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.5343","article-title":"Next generation pathology: artificial intelligence enhances histopathology practice","volume":"250","author":"Acs","year":"2020","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.clcc.2020.04.002_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.clcc.2020.04.002_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2019.03.016","article-title":"Tumour regression after radiotherapy for rectal cancer - results from the randomised Stockholm III trial","volume":"135","author":"Erlandsson","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fonc.2014.00050","article-title":"Optimal time intervals between pre-operative radiotherapy or chemoradiotherapy and surgery in rectal cancer?","volume":"4","author":"Glimelius","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib24","doi-asserted-by":"crossref","first-page":"e185896","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib25","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/annonc\/mdz194","article-title":"Extending the interval to surgery in rectal cancer and filling the time with chemotherapy\u2014how much is enough?","volume":"30","author":"Glynne-Jones","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc.2018.1","article-title":"Tumour budding in colorectal cancer: molecular rationale for clinical translation","volume":"18","author":"Zlobec","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clcc.2020.04.002_bib27","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.04.002_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2407-13-279","article-title":"Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial","volume":"13","author":"Nilsson","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2020.04.002_bib29","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/cncr.32150","article-title":"National Cancer Institute (NCI) state of the science: targeted radiosensitizers in colorectal cancer","volume":"125","author":"George","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2020.04.002_bib30","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1172\/JCI128562","article-title":"In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors","volume":"129","author":"Khalil","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clcc.2020.04.002_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-0037-1602239","article-title":"The role of the gut microbiome in colorectal cancer","volume":"31","author":"Chen","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.clcc.2020.04.002_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820300487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820300487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:06:52Z","timestamp":1761520012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002820300487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1533002820300487"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2020.04.002","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}